Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900021265Phase 4Recruiting
Phase 4, randomised, open-label trial of dexmedetomidine and ropivacaine in postoperative pain (4 arms), sponsored by Ningbo Medical Center Lihuili Eastern Hospital. Primary endpoints: Analgesic indicators, Movement indicators and 1 more. Started Feb 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900021265.